RSV: The Injection Keeping Babies Out Of Hospital

RSV season is here, and Ireland’s infant RSV immunisation programme is now in its third winter. In this episode, Afif and Anne explain what RSV does to babies, why some develop bronchiolitis severe enough to need hospital care, and revisit their own experience when their 4-week-old son was admitted with RSV. They also look at nirsevimab, the long-acting antibody now used to protect babies through RSV season, and the latest evidence showing substantial reductions in RSV-related hospitalisations in both Australia and Ireland. They discuss who is eligible in Ireland, how the immunisation works, side effects, and why preventing RSV admissions matters for both families and the wider hospital system. Useful links HSE: RSV immunisation for babies Queensland nirsevimab study